The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients

The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients

In 2013, Centers for Disease Control and Prevention released a revised central line-associated bloodstream infection (CLABSI) surveillance protocol which differentiates laboratory-confirmed bloodstream infection (LCBI) from mucosal barrier injury LCBI (MBI-LCBI). The objectives of this study were to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of infection control 2014-06, Vol.42 (6), p.S12-S13
Hauptverfasser: Metzger, Kristen, MPH, CIC, Rucker, Yvonne, MSN, RN, NE-BC, OCN, Callaghan, Mary, MN, RN, AOCNS, APN, Churchill, Michelle, MSN, ANP-BC, OCN, Bolon, Maureen, MD, MS
Format: Artikel
Sprache:eng
Schlagworte:
Blood
Infection Control
Infections
Infectious Disease
Stem cells
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S13
container_issue 6
container_start_page S12
container_title American journal of infection control
container_volume 42
creator Metzger, Kristen, MPH, CIC
Rucker, Yvonne, MSN, RN, NE-BC, OCN
Callaghan, Mary, MN, RN, AOCNS, APN
Churchill, Michelle, MSN, ANP-BC, OCN
Bolon, Maureen, MD, MS
description In 2013, Centers for Disease Control and Prevention released a revised central line-associated bloodstream infection (CLABSI) surveillance protocol which differentiates laboratory-confirmed bloodstream infection (LCBI) from mucosal barrier injury LCBI (MBI-LCBI). The objectives of this study were to determine the proportion of CLABSIs classified as MBI-LCBI among hematology/oncology (Heme/Onc) and stem cell transplant patients (SCT), compare characteristics of non-MBI LCBI and MBI-LCBI cases, and evaluate how CLABSI prevention efforts affect non-MBI LCBI and MBI-LCBI rates.
doi_str_mv 10.1016/j.ajic.2014.03.049
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1554302104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196655314002727</els_id><sourcerecordid>3406728781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1794-1c0f7f03e72ba4c80e4e564556e6a1501d9a49b2ad1b1cd5ca42cc937f97b1b53</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxiNEJZaWF-BkiStJx_8SIiGk7gpopUWt1OVsOc6kOCT2YieV8g59aJwuEhIHTjOH75v55jdZ9pZCQYGWl32he2sKBlQUwAsQ9YtsQyWrcs7q8mW2AVqXeSklf5W9jrEHgJqXcpM9HX4g2c6hRUd8R77Nxkc9kK0OwWIgN66fw0L2uvFBTz4sufGus2HElmwH79s4BdRj0nVoJusduRq9eyDXOCb54B-W9-TWmeeOaNeS-wlHssNhIIegXTwO2k3kTk8W3RQvsrNODxHf_Knn2fcvnw-763x_-_Vmd7XPDa1qkVMDXdUBx4o1WpgPgAJlKaQssdRUAm1rLeqG6ZY21LTSaMGMqXnV1VVDG8nPs3enucfgf80YJ9X7Obi0UlEpBQdGQSQVO6lM8DEG7NQx2FGHRVFQK3XVq5W6Wqkr4CpRT6aPJxOm_I8JoYom3WawtSERUq23_7d_-sduBuus0cNPXDD-jakiU6Du17euX6UCgFWs4r8BMJmhtg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1554302104</pqid></control><display><type>article</type><title>The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients</title><source>Elsevier ScienceDirect Journals</source><creator>Metzger, Kristen, MPH, CIC ; Rucker, Yvonne, MSN, RN, NE-BC, OCN ; Callaghan, Mary, MN, RN, AOCNS, APN ; Churchill, Michelle, MSN, ANP-BC, OCN ; Bolon, Maureen, MD, MS</creator><creatorcontrib>Metzger, Kristen, MPH, CIC ; Rucker, Yvonne, MSN, RN, NE-BC, OCN ; Callaghan, Mary, MN, RN, AOCNS, APN ; Churchill, Michelle, MSN, ANP-BC, OCN ; Bolon, Maureen, MD, MS</creatorcontrib><description>In 2013, Centers for Disease Control and Prevention released a revised central line-associated bloodstream infection (CLABSI) surveillance protocol which differentiates laboratory-confirmed bloodstream infection (LCBI) from mucosal barrier injury LCBI (MBI-LCBI). The objectives of this study were to determine the proportion of CLABSIs classified as MBI-LCBI among hematology/oncology (Heme/Onc) and stem cell transplant patients (SCT), compare characteristics of non-MBI LCBI and MBI-LCBI cases, and evaluate how CLABSI prevention efforts affect non-MBI LCBI and MBI-LCBI rates.</description><identifier>ISSN: 0196-6553</identifier><identifier>EISSN: 1527-3296</identifier><identifier>DOI: 10.1016/j.ajic.2014.03.049</identifier><language>eng</language><publisher>St. Louis: Mosby, Inc</publisher><subject>Blood ; Infection Control ; Infections ; Infectious Disease ; Stem cells ; Transplants &amp; implants</subject><ispartof>American journal of infection control, 2014-06, Vol.42 (6), p.S12-S13</ispartof><rights>2014</rights><rights>Copyright Mosby-Year Book, Inc. Jun 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajic.2014.03.049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids></links><search><creatorcontrib>Metzger, Kristen, MPH, CIC</creatorcontrib><creatorcontrib>Rucker, Yvonne, MSN, RN, NE-BC, OCN</creatorcontrib><creatorcontrib>Callaghan, Mary, MN, RN, AOCNS, APN</creatorcontrib><creatorcontrib>Churchill, Michelle, MSN, ANP-BC, OCN</creatorcontrib><creatorcontrib>Bolon, Maureen, MD, MS</creatorcontrib><title>The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients</title><title>American journal of infection control</title><description>In 2013, Centers for Disease Control and Prevention released a revised central line-associated bloodstream infection (CLABSI) surveillance protocol which differentiates laboratory-confirmed bloodstream infection (LCBI) from mucosal barrier injury LCBI (MBI-LCBI). The objectives of this study were to determine the proportion of CLABSIs classified as MBI-LCBI among hematology/oncology (Heme/Onc) and stem cell transplant patients (SCT), compare characteristics of non-MBI LCBI and MBI-LCBI cases, and evaluate how CLABSI prevention efforts affect non-MBI LCBI and MBI-LCBI rates.</description><subject>Blood</subject><subject>Infection Control</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Stem cells</subject><subject>Transplants &amp; implants</subject><issn>0196-6553</issn><issn>1527-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxiNEJZaWF-BkiStJx_8SIiGk7gpopUWt1OVsOc6kOCT2YieV8g59aJwuEhIHTjOH75v55jdZ9pZCQYGWl32he2sKBlQUwAsQ9YtsQyWrcs7q8mW2AVqXeSklf5W9jrEHgJqXcpM9HX4g2c6hRUd8R77Nxkc9kK0OwWIgN66fw0L2uvFBTz4sufGus2HElmwH79s4BdRj0nVoJusduRq9eyDXOCb54B-W9-TWmeeOaNeS-wlHssNhIIegXTwO2k3kTk8W3RQvsrNODxHf_Knn2fcvnw-763x_-_Vmd7XPDa1qkVMDXdUBx4o1WpgPgAJlKaQssdRUAm1rLeqG6ZY21LTSaMGMqXnV1VVDG8nPs3enucfgf80YJ9X7Obi0UlEpBQdGQSQVO6lM8DEG7NQx2FGHRVFQK3XVq5W6Wqkr4CpRT6aPJxOm_I8JoYom3WawtSERUq23_7d_-sduBuus0cNPXDD-jakiU6Du17euX6UCgFWs4r8BMJmhtg</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Metzger, Kristen, MPH, CIC</creator><creator>Rucker, Yvonne, MSN, RN, NE-BC, OCN</creator><creator>Callaghan, Mary, MN, RN, AOCNS, APN</creator><creator>Churchill, Michelle, MSN, ANP-BC, OCN</creator><creator>Bolon, Maureen, MD, MS</creator><general>Mosby, Inc</general><general>Mosby-Year Book, Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140601</creationdate><title>The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients</title><author>Metzger, Kristen, MPH, CIC ; Rucker, Yvonne, MSN, RN, NE-BC, OCN ; Callaghan, Mary, MN, RN, AOCNS, APN ; Churchill, Michelle, MSN, ANP-BC, OCN ; Bolon, Maureen, MD, MS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1794-1c0f7f03e72ba4c80e4e564556e6a1501d9a49b2ad1b1cd5ca42cc937f97b1b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Blood</topic><topic>Infection Control</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Stem cells</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Metzger, Kristen, MPH, CIC</creatorcontrib><creatorcontrib>Rucker, Yvonne, MSN, RN, NE-BC, OCN</creatorcontrib><creatorcontrib>Callaghan, Mary, MN, RN, AOCNS, APN</creatorcontrib><creatorcontrib>Churchill, Michelle, MSN, ANP-BC, OCN</creatorcontrib><creatorcontrib>Bolon, Maureen, MD, MS</creatorcontrib><collection>CrossRef</collection><jtitle>American journal of infection control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Metzger, Kristen, MPH, CIC</au><au>Rucker, Yvonne, MSN, RN, NE-BC, OCN</au><au>Callaghan, Mary, MN, RN, AOCNS, APN</au><au>Churchill, Michelle, MSN, ANP-BC, OCN</au><au>Bolon, Maureen, MD, MS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients</atitle><jtitle>American journal of infection control</jtitle><date>2014-06-01</date><risdate>2014</risdate><volume>42</volume><issue>6</issue><spage>S12</spage><epage>S13</epage><pages>S12-S13</pages><issn>0196-6553</issn><eissn>1527-3296</eissn><abstract>In 2013, Centers for Disease Control and Prevention released a revised central line-associated bloodstream infection (CLABSI) surveillance protocol which differentiates laboratory-confirmed bloodstream infection (LCBI) from mucosal barrier injury LCBI (MBI-LCBI). The objectives of this study were to determine the proportion of CLABSIs classified as MBI-LCBI among hematology/oncology (Heme/Onc) and stem cell transplant patients (SCT), compare characteristics of non-MBI LCBI and MBI-LCBI cases, and evaluate how CLABSI prevention efforts affect non-MBI LCBI and MBI-LCBI rates.</abstract><cop>St. Louis</cop><pub>Mosby, Inc</pub><doi>10.1016/j.ajic.2014.03.049</doi></addata></record>
fulltext fulltext
identifier ISSN: 0196-6553
ispartof American journal of infection control, 2014-06, Vol.42 (6), p.S12-S13
issn 0196-6553
1527-3296
language eng
recordid cdi_proquest_journals_1554302104
source Elsevier ScienceDirect Journals
subjects Blood
Infection Control
Infections
Infectious Disease
Stem cells
Transplants & implants
title The Burden of Mucosal Barrier Injury Laboratory-confirmed Bloodstream Infection Among Hematology, Oncology and Stem Cell Transplant Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T06%3A38%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Burden%20of%20Mucosal%20Barrier%20Injury%20Laboratory-confirmed%20Bloodstream%20Infection%20Among%20Hematology,%20Oncology%20and%20Stem%20Cell%20Transplant%20Patients&rft.jtitle=American%20journal%20of%20infection%20control&rft.au=Metzger,%20Kristen,%20MPH,%20CIC&rft.date=2014-06-01&rft.volume=42&rft.issue=6&rft.spage=S12&rft.epage=S13&rft.pages=S12-S13&rft.issn=0196-6553&rft.eissn=1527-3296&rft_id=info:doi/10.1016/j.ajic.2014.03.049&rft_dat=%3Cproquest_cross%3E3406728781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1554302104&rft_id=info:pmid/&rft_els_id=S0196655314002727&rfr_iscdi=true